Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8276
PUT
DHT Holdings
DHT
$3.14B
| $119K | ﹤0.01% |
20,100
-15,600
| -44% | -$85K |
|
8277
PUT
IDT Corp
IDT
$1.66B
| $119K | ﹤0.01% |
12,600
-10,000
| -44% | -$73.7K |
|
8278
PUT
Quad
QUAD
$513M
| $119K | ﹤0.01% |
15,000
-155,500
| -91% | -$1.63M |
|
|
SMC
8279
PUT
Summit Midstream
SMC
$482M
| $119K | ﹤0.01% |
1,067
-1,840
| -63% | -$224K |
|
|
KA
8280
DELISTED
Kineta, Inc. Common Stock
KA
| $119K | ﹤0.01% |
872
+222
| +34% | +$34.5K |
|
|
VSLR
8281
CALL
DELISTED
VIVINT SOLAR, INC.
VSLR
| $119K | ﹤0.01% |
16,300
-27,800
| -63% | -$176K |
|
|
SORL
8282
PUT
DELISTED
SORL Auto Parts, Inc.
SORL
| $119K | ﹤0.01% |
34,300
+8,600
| +33% | +$29.4K |
|
8283
Harvard Bioscience
HBIO
$30.3M
| $118K | ﹤0.01% |
+5,867
| New | +$172K |
|
|
NETI
8284
CALL
DELISTED
Eneti Inc.
NETI
| $118K | ﹤0.01% |
+2,755
| New | +$118K |
|
|
PTNR
8285
DELISTED
Partner Communications
PTNR
| $118K | ﹤0.01% |
28,081
-1,564
| -5% | -$6.94K |
|
|
ALDR
8286
PUT
DELISTED
Alder Biopharmaceuticals
ALDR
| $118K | ﹤0.01% |
+10,000
| New | +$121K |
|
8287
PUT
Vuzix
VUZI
$258M
| $117K | ﹤0.01% |
28,700
-48,000
| -63% | -$137K |
|
|
AGEN
8288
CALL
Agenus
AGEN
$329M
| $116K | ﹤0.01% |
1,977
-117
| -6% | -$6.39K |
|
8289
Immersion
IMMR
$249M
| $116K | ﹤0.01% |
15,178
-56,005
| -79% | -$473K |
|
|
STR
8290
DELISTED
Sitio Royalties
STR
| $116K | ﹤0.01% |
+3,463
| New | +$114K |
|
8291
CALL
ADT
ADT
$5.47B
| $115K | ﹤0.01% |
18,800
-9,600
| -34% | -$61.1K |
|
8292
PUT
Pacific Biosciences
PACB
$357M
| $115K | ﹤0.01% |
+19,000
| New | +$133K |
|
|
ZAGG
8293
CALL
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $115K | ﹤0.01% |
16,500
+4,800
| +41% | +$36.1K |
|
8294
PUT
Anavex Life Sciences
AVXL
$298M
| $114K | ﹤0.01% |
33,800
+15,400
| +84% | +$47.8K |
|
8295
PUT
Karyopharm Therapeutics
KPTI
$45.8M
| $114K | ﹤0.01% |
1,273
-594
| -32% | -$47.7K |
|
|
TRVN
8296
DELISTED
Trevena, Inc.
TRVN
| $114K | ﹤0.01% |
178
+145
| +439% | +$119K |
|
|
NAK
8297
PUT
Northern Dynasty Minerals
NAK
$908M
| $113K | ﹤0.01% |
188,500
+6,600
| +4% | +$3.43K |
|
8298
CALL
Siebert Financial
SIEB
$78.9M
| $113K | ﹤0.01% |
12,600
+2,200
| +21% | +$21.9K |
|
|
SPPI
8299
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $113K | ﹤0.01% |
13,100
-4,200
| -24% | -$37.6K |
|
|
ZAGG
8300
PUT
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $113K | ﹤0.01% |
16,200
-16,300
| -50% | -$123K |
|
Similar funds
Citadel Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
- Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
- Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.